23 January 2019 - Believe it or not, there is a chance President Trump and congressional Democrats can reach an agreement this year to limit the growth in Medicare drug prices. 

It certainly won’t be easy, given the toxic relationship the president and Democrats have built up in just the past few weeks. But both sides have good reasons to make a deal, and they may not be that far apart on the substance of an agreement.

After all, lowering drug prices has been on the Democratic agenda for years while Trump has been talking about the idea since the early days of his presidential campaign. And, as with many issues, he has been extremely flexible about how to do it. At times, he’s even seemed to embrace proposals such as allowing Americans to import drugs directly from Canada or even having government negotiate prices with drug makers—ideas that have strong support among progressive Democrats.

Read Forbes article